AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 100 filers reported holding AVROBIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $179,079,000 | -37.2% | 32,093 | 0.0% | 0.00% | – |
| Q2 2021 | $285,307,000 | -91.8% | 32,093 | -88.2% | 0.00% | -100.0% |
| Q1 2021 | $3,461,617,000 | -8.6% | 272,783 | +0.4% | 0.00% | 0.0% |
| Q4 2020 | $3,789,087,000 | -1.9% | 271,814 | -8.4% | 0.00% | 0.0% |
| Q3 2020 | $3,863,073,000 | -23.9% | 296,703 | +2.0% | 0.00% | -33.3% |
| Q2 2020 | $5,077,653,000 | +18.7% | 290,983 | +5.9% | 0.00% | 0.0% |
| Q1 2020 | $4,277,132,000 | +24.5% | 274,880 | +61.1% | 0.00% | +50.0% |
| Q4 2019 | $3,434,943,000 | +65.2% | 170,638 | +15.9% | 0.00% | +100.0% |
| Q3 2019 | $2,079,495,000 | -13.2% | 147,273 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $2,394,659,000 | -28.0% | 147,273 | -2.4% | 0.00% | 0.0% |
| Q1 2019 | $3,325,537,000 | +30.1% | 150,818 | -1.8% | 0.00% | 0.0% |
| Q4 2018 | $2,556,341,000 | -59.8% | 153,534 | +25.4% | 0.00% | -60.0% |
| Q3 2018 | $6,352,311,000 | +90.1% | 122,466 | +4.7% | 0.01% | +66.7% |
| Q2 2018 | $3,341,520,000 | – | 117,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |